SHAHID ULLAH; ALEX TONKS; , Abdulsalam M Alruwaili; HEDIB ALKOUMI H ALRAWILI; ASIFULLAH KHAN; AHMAD SALEM ALANAZI; AMIRAH SAYAH S ALKUWAYKIBI; CARLOS ELIEL MAYA-RAMÍREZ; MUHAMMAD ARIF LODHI. STRUCTURE-BASED VIRTUAL SCREENING STUDY OF FDA‑APPROVED DRUGS TO INHIBIT TP53 72 ARG/PRO VARIANT IDENTIFIED IN ACUTE LYMPHOCYTIC PATIENT VIA WHOLE EXOME SEQUENCING. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 3, p. 2304–2415, 2024. DOI: 10.53555/jptcp.v31i3.5046. Disponível em: https://jptcp.com/index.php/jptcp/article/view/5046. Acesso em: 11 oct. 2025.